샘플 요청 목록

 카트 문의
시장보고서
상품코드
1873189

세계의 생세포 이미징 시장

Live Cell Imaging
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 189 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생세포 이미징 시장은 2030년까지 44억 달러에 달할 전망

2024년에 29억 달러로 추정되는 세계의 생세포 이미징 시장은 2024-2030년의 분석 기간에 CAGR 7.4%로 성장하며, 2030년까지 44억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상이 된 부문의 하나인 세포생물학 용도는 6.2%의 CAGR을 기록하며, 분석 기간 종료까지 18억 달러에 달할 것으로 예측됩니다. Drug Discovery 용도 부문의 성장률은 분석 기간에 8.5%의 CAGR로 추정되고 있습니다.

미국 시장은 7억 9,610만 달러로 추정되는 한편, 중국은 7.1%의 CAGR로 성장할 것으로 예측됩니다.

미국의 생세포 이미징 시장은 2024년에 7억 9,610만 달러로 추정되고 있습니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 7.1%로 추이하며, 2030년까지 6억 8,690만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 CAGR 6.7%, 6.1%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 6.2%의 CAGR로 성장할 것으로 예측됩니다.

세계의 생세포 이미징 시장 - 주요 시장 동향과 촉진요인의 개요

생세포 이미징은 생의학 연구를 어떻게 변화시키고 있는가?

생세포 이미징은 과학자들이 살아있는 세포 내에서 시간에 따라 일어나는 역동적인 과정을 관찰하고 분석할 수 있게 함으로써 생의학 연구를 근본적으로 변화시켰습니다. 고정된 세포의 정지된 이미지를 캡처하는 기존의 방법과는 달리, 생세포 이미징을 통해 연구자들은 실시간 생물학적 과정을 연구할 수 있으며, 세포의 거동에 대한 전례 없는 인사이트를 제공합니다. 이 기술은 세포의 변화와 상호작용에 대한 이해가 지식의 발전과 새로운 치료법 개발에 필수적인 암 연구, 신경과학, 면역학 등의 분야에서 특히 가치가 있습니다. 예를 들어 암 연구에서는 생세포 이미징을 통해 종양세포의 이동, 증식, 치료 반응을 관찰하여 암의 전이 기전 및 효과적인 표적 치료법에 대한 중요한 정보를 얻고 있습니다. 마찬가지로 신경과학 분야에서는 신경 연결, 시냅스 활동, 다양한 조건에서 뇌세포의 거동을 연구하는 데 있으며, 생세포 이미징이 필수적입니다. 형광 현미경 및 공초점 이미징과 같은 첨단 이미징 기술의 발전으로 연구자들은 이제 살아있는 세포내 특정 단백질, 세포 소기관 및 세포내 경로의 거동을 보다 선명하고 높은 해상도로 시각화할 수 있게 되었습니다. 이러한 능력은 질병 메커니즘, 약물 효과, 세포 반응을 이해하는 새로운 길을 열어 생세포 이미징을 현대 생의학 연구에 필수적인 툴로 만들고 있습니다.

생세포 이미징이 세포 동역학 이해에 필수적인 이유는 무엇인가?

생세포 이미징은 세포의 기능, 상호 작용 및 다양한 자극에 대한 반응을 이해하는 데 핵심적인 세포내 동적 과정을 조사하는 데 매우 중요합니다. 특정 시점의 단일 스냅숏을 제공하는 기존의 고정 세포 이미징 기술과 달리, 생세포 이미징은 실시간으로 세포를 지속적으로 관찰할 수 있으며, 전개되는 세포 활동의 전체 범위를 포착할 수 있습니다. 특히 세포가 시간이 지남에 따라 다른 화합물에 어떻게 반응하는지를 이해하는 것은 잠재적인 치료 후보를 식별하는 데 필수적인 연구개발에 있으며, 매우 중요합니다. 생세포 이미징을 통해 세포의 이동, 분열, 세포사멸(프로그램된 세포사멸)과 같은 중요한 과정과 면역세포의 병원체 및 암세포 표적화와 같은 보다 복잡한 상호 작용을 관찰할 수 있습니다. 줄기세포 연구 분야에서는 줄기세포가 다양한 세포 유형으로 분화되는 과정을 추적하는 데 필수적이며, 재생의료에서 줄기세포를 활용하는 방법에 대한 지식을 제공합니다. 세포내 동역학을 시각화하는 능력은 질병을 세포 수준에서 조사하는 데 도움이 되며, 암, 신경퇴행성 질환, 심혈관 질환 등의 병태생리에 관여하는 기능장애 경로와 비정상적인 세포 행동을 규명하는 데 도움이 됩니다. 생세포 이미징은 세포의 내부 메커니즘을 실시간으로 관찰할 수 있는 창을 제공함으로써 기초 연구와 임상 적용을 촉진하는 데 필수적인 역할을 하고 있습니다.

기술 발전은 생세포 이미징을 어떻게 향상시키고 있는가?

기술 혁신은 생세포 이미징을 획기적으로 개선하여 이 중요한 연구 툴의 해상도와 기능을 향상시키고 있습니다. 가장 획기적인 혁신 중 하나는 초해상도 현미경 기술로, 기존 광학 현미경의 한계를 훨씬 뛰어넘는 나노 스케일에서 세포 구조와 분자 간 상호작용을 관찰할 수 있게 해줍니다. 이 획기적인 기술을 통해 단백질 간 상호작용, DNA 복제, 세포내 운송의 미세한 디테일을 전례 없는 정밀도로 조사할 수 있게 되었습니다. 또 다른 중요한 발전은 보다 진보된 형광 마커와 염료의 개발입니다. 이들은 특정 세포 성분을 표지하여 실시간으로 시각화할 수 있습니다. 이러한 마커는 현재 더 안정적이고 광독성이 낮기 때문에 세포를 손상시키거나 세포의 거동을 변화시키지 않고 더 오랜 시간 동안 이미징을 할 수 있습니다. 자동화와 결합된 타임랩스 이미징도 진화하여, 연구자들은 세포의 거동을 장기간에 걸쳐 모니터링할 수 있게 되었습니다. 이를 통해 세포분열, 분화, 면역반응 등의 과정을 수 시간에서 수일에 걸쳐 포착할 수 있습니다. 또한 데이터 분석 기술, 특히 인공지능(AI)과 머신러닝의 통합으로 생세포 이미징이 생성하는 방대한 데이터를 해석할 수 있는 능력이 크게 향상되었습니다. AI 기반 소프트웨어는 패턴을 자동 식별하고, 세포의 움직임을 추적하고, 세포 행동의 변화를 정량화할 수 있게 되었습니다. 이를 통해 조사자의 부담을 줄이고 조사 결과의 정확성을 향상시키고 있습니다. 이러한 기술 혁신은 생세포 이미징의 능력을 확장했을 뿐만 아니라 기초 세포 생물학에서 임상 진단에 이르기까지 보다 광범위한 조사 분야에서 이 기술을 쉽게 사용할 수 있도록 했습니다.

생세포 이미징 시장의 성장을 가속하는 요인은 무엇인가?

생세포 이미징 시장의 성장은 이미징 기술의 발전, 세포 기반 연구에 대한 수요 증가, 상세한 세포 분석이 필요한 만성질환 증가 등 여러 요인에 의해 촉진되고 있습니다. 주요 촉진요인 중 하나는 신약 및 의약품 개발에서 생세포 이미징의 역할 확대입니다. 제약사들은 이 기술을 이용해 약물 후보물질에 대한 세포 반응을 실시간으로 관찰하고, 약물의 효능과 독성을 보다 정확하게 평가했습니다. 맞춤형 의료의 부상도 수요를 촉진하고 있으며, 연구자들은 생세포 이미징을 사용하여 개별 세포가 특정 치료에 어떻게 반응하는지 탐구하고 환자의 고유한 생물학적 프로파일에 맞는 치료법을 설계하는 데 기여하고 있습니다. 또한 암 연구, 면역치료, 재생의료에 대한 관심이 높아짐에 따라 종양 진행, 면역세포 기능, 줄기세포 분화 등의 과정을 조사하기 위해 생세포 이미징에 대한 의존도가 높아지고 있습니다. 고해상도 현미경과 초해상도 현미경의 개발 등 이미징 시스템의 기술 발전으로 생세포 이미징은 더욱 효과적이고 쉽게 이용할 수 있게 되었으며, 연구자들은 세포의 거동을 더욱 선명하고 세밀하게 관찰할 수 있게 되었습니다. 암, 신경퇴행성 질환, 심혈관 질환 등 만성질환의 유병률 증가도 생세포 이미징 수요를 견인하고 있습니다. 과학자들은 이러한 질병의 배경이 되는 세포 메커니즘을 이해하고 보다 효과적인 치료법을 개발하기 위해 노력하고 있기 때문입니다. 또한 생명과학 연구에 대한 투자 확대와 첨단 이미징 기술에 대한 정부 자금 증가가 맞물려 생세포 이미징 시장 확대에 기여하고 있습니다. 생세포 이미징은 생의학 연구 분야가 계속 진화하는 가운데, 연구와 임상 용도에서 혁신과 성장을 주도하는 중요한 툴이 될 것으로 예측됩니다.

부문:

컴포넌트(기기, 소모품, 소프트웨어), 용도(세포생물학, Drug Discovery, 발생생물학, 줄기세포), 최종사용처(제약/바이오기업, 학술·연구기관, 병원·진단 검사실)

조사 대상 기업의 예

  • ATTO Corporation
  • Becton, Dickinson and Company
  • Biological Industries Israel Beit-Haemek
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Carl Zeiss AG
  • Enzo Life Sciences, Inc.
  • Essen BioScience, Inc.
  • GE Healthcare
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석 방식을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM이나 산업별 SLM에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA 25.11.26

Global Live Cell Imaging Market to Reach US$4.4 Billion by 2030

The global market for Live Cell Imaging estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Cell Biology Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Drug Discovery Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$796.1 Million While China is Forecast to Grow at 7.1% CAGR

The Live Cell Imaging market in the U.S. is estimated at US$796.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$686.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Live Cell Imaging Market - Key Trends and Drivers Summarized

How Is Live Cell Imaging Revolutionizing Biomedical Research?

Live cell imaging has fundamentally transformed biomedical research by enabling scientists to observe and analyze the dynamic processes occurring in living cells over time. Unlike traditional methods, which capture static images of fixed cells, live cell imaging allows researchers to study real-time biological processes, offering unprecedented insights into cellular behavior. This technique is especially valuable in fields like cancer research, neuroscience, and immunology, where understanding cellular changes and interactions is critical for advancing knowledge and developing new therapies. In cancer research, for example, live cell imaging is used to observe how tumor cells migrate, proliferate, and respond to treatments, providing vital information on how cancers metastasize and how they can be targeted more effectively. Similarly, in neuroscience, live cell imaging is essential for studying neural connections, synaptic activity, and the behavior of brain cells under different conditions. With the development of advanced imaging technologies like fluorescence microscopy and confocal imaging, researchers can now visualize the behavior of specific proteins, organelles, and cellular pathways in living cells with greater clarity and resolution. These capabilities have opened new avenues for understanding disease mechanisms, drug effects, and cellular responses, making live cell imaging an indispensable tool in modern biomedical research.

Why Is Live Cell Imaging Critical for Understanding Cellular Dynamics?

Live cell imaging is crucial for studying the dynamic processes within cells that are central to understanding how they function, interact, and respond to various stimuli. Unlike traditional fixed-cell imaging techniques, which offer a single snapshot in time, live cell imaging provides continuous observation of cells in real time, allowing researchers to capture the full range of cellular activities as they unfold. This is particularly important in drug development, where understanding how cells react to different compounds over time is essential for identifying potential therapeutic candidates. Live cell imaging enables researchers to observe critical processes like cell migration, division, and apoptosis (programmed cell death), as well as more complex interactions such as immune cell targeting of pathogens or cancer cells. In the field of stem cell research, live cell imaging is indispensable for tracking the differentiation of stem cells into various cell types, providing insights into how stem cells can be used in regenerative medicine. The ability to visualize intracellular dynamics also aids in studying diseases at the cellular level, helping scientists to identify malfunctioning pathways or abnormal cell behaviors that contribute to conditions like cancer, neurodegenerative disorders, and cardiovascular diseases. By offering a real-time window into the inner workings of cells, live cell imaging has become essential for advancing both basic research and clinical applications.

How Are Technological Advancements Enhancing Live Cell Imaging?

Technological advancements are driving significant improvements in live cell imaging, enhancing both the resolution and functionality of this critical research tool. One of the most transformative innovations is super-resolution microscopy, which allows researchers to observe cellular structures and molecular interactions at a nanoscopic scale, far beyond the limits of traditional light microscopy. This breakthrough has made it possible to study the fine details of protein-protein interactions, DNA replication, and intracellular transport with unprecedented precision. Another key advancement is the development of more sophisticated fluorescent markers and dyes, which enable the labeling of specific cellular components for real-time visualization. These markers are now more stable and less phototoxic, allowing for longer imaging sessions without damaging the cells or altering their behavior. Time-lapse imaging, combined with automation, has also evolved, allowing researchers to monitor cell behavior over extended periods-capturing processes like cell division, differentiation, or the immune response over several hours or days. Additionally, advancements in data analysis, particularly the integration of artificial intelligence (AI) and machine learning, have greatly improved the ability to interpret the vast amount of data generated by live cell imaging. AI-powered software can now automatically identify patterns, track cellular movements, and quantify changes in cellular behavior, reducing the burden on researchers and increasing the accuracy of their findings. These technological innovations have not only expanded the capabilities of live cell imaging but have also made the technology more accessible to a broader range of research applications, from basic cell biology to clinical diagnostics.

What Are the Factors Fueling Growth in the Live Cell Imaging Market?

The growth in the live cell imaging market is driven by several factors, including advancements in imaging technologies, the increasing demand for cell-based research, and the growing prevalence of chronic diseases that require detailed cellular analysis. One of the primary drivers is the expanding role of live cell imaging in drug discovery and development. Pharmaceutical companies rely on this technology to observe cellular responses to drug candidates in real time, enabling them to assess drug efficacy and toxicity more accurately. The rise of personalized medicine is also fueling demand, as researchers use live cell imaging to explore how individual cells react to specific treatments, helping to tailor therapies to patients' unique biological profiles. Furthermore, the increasing focus on cancer research, immunotherapy, and regenerative medicine has led to greater reliance on live cell imaging to study processes like tumor progression, immune cell function, and stem cell differentiation. Technological advancements in imaging systems, such as the development of high-resolution and super-resolution microscopes, are making live cell imaging more effective and accessible, allowing researchers to obtain clearer and more detailed views of cellular behavior. The rising prevalence of chronic diseases like cancer, neurodegenerative disorders, and cardiovascular diseases is also driving demand for live cell imaging, as scientists seek to understand the cellular mechanisms behind these conditions and develop more effective treatments. Additionally, growing investments in life sciences research, coupled with increased government funding for advanced imaging technologies, are contributing to the expansion of the live cell imaging market. As the field of biomedical research continues to evolve, live cell imaging is expected to remain a crucial tool, driving further innovation and growth in both research and clinical applications.

SCOPE OF STUDY:

The report analyzes the Live Cell Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Instruments, Consumables, Software); Application (Cell Biology, Drug Discovery, Developmental Biology, Stem Cells); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Labs)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • ATTO Corporation
  • Becton, Dickinson and Company
  • Biological Industries Israel Beit-Haemek
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Carl Zeiss AG
  • Enzo Life Sciences, Inc.
  • Essen BioScience, Inc.
  • GE Healthcare
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Live Cell Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Live Cell Imaging in Drug Discovery Expands Market Opportunities
    • Advancements in Fluorescence and Super-Resolution Microscopy Propel Market Growth
    • Growing Focus on Real-Time Cellular Analysis Strengthens Demand for Live Cell Imaging Technologies
    • Rising Importance of Cell-Based Assays in Research Drives Adoption of Live Cell Imaging
    • Integration of Artificial Intelligence in Image Analysis Spurs Efficiency in Live Cell Imaging
    • Increasing Use of Live Cell Imaging in Cancer Research Boosts Market Expansion
    • Growing Investment in Stem Cell Research Drives Need for Live Cell Imaging Solutions
    • Expansion of 3D Cell Culture Models Accelerates Growth of Live Cell Imaging Applications
    • Emerging Applications in Neuroscience Create New Market Opportunities for Live Cell Imaging
    • Rising Prevalence of Chronic Diseases Strengthens Need for Advanced Live Cell Imaging Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Developmental Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Developmental Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Developmental Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Hospitals & Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Hospitals & Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Live Cell Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Live Cell Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Live Cell Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Live Cell Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • JAPAN
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • CHINA
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • EUROPE
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Live Cell Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Live Cell Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Live Cell Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • GERMANY
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Live Cell Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Live Cell Imaging by Application - Cell Biology, Drug Discovery, Developmental Biology and Stem Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Live Cell Imaging by Application - Percentage Breakdown of Value Sales for Cell Biology, Drug Discovery, Developmental Biology and Stem Cells for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Live Cell Imaging by Component - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Live Cell Imaging by Component - Instruments, Consumables and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Live Cell Imaging by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Live Cell Imaging by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Live Cell Imaging by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Labs for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제